Front Page - Insurance Investor

|

Sign in /

Sign In / Subscribe

RISK

Fed keeps interest rates steady as inflation fears mount

Fed keeps interest rates steady as inflation fears mount

January 29, 2026

AI tops Risk Barometer for first time with fears of rapid societal change

AI tops Risk Barometer for first time with fears of rapid societal change

January 15, 2026

What are the big fixed income indicators showing?

What are the big fixed income indicators showing?

January 14, 2026

Bank of England tests private credit industry, what’s next?

Bank of England tests private credit industry, what’s next?

December 8, 2025

TREASURY & FINANCE

Private equity increases hold on insurers

Private equity increases hold on insurers

January 29, 2026

Travelers Q4 2025 net investment up 10% year-on-year

Travelers Q4 2025 net investment up 10% year-on-year

January 26, 2026

Mansion House Accord, Solvency UK, best ways to secure long-term growth

Mansion House Accord, Solvency UK, best ways to secure long-term growth

December 9, 2025

Long-term repercussions for insurers from the 2025 budget

Long-term repercussions for insurers from the 2025 budget

December 3, 2025

STRATEGY

"Sell America" trend continues - will it be inflationary?

"Sell America" trend continues - will it be inflationary?

January 29, 2026

Insurance Investor | European Awards 2026 – ENTRY NOW OPEN

Insurance Investor | European Awards 2026 – ENTRY NOW OPEN

January 28, 2026

W.R. Berkley nets record investment income in Q4

W.R. Berkley nets record investment income in Q4

January 27, 2026

How should investors play the “Donroe Doctrine”?

How should investors play the “Donroe Doctrine”?

January 27, 2026

EVENTS

Insurance Investor Live | North America 2026

Insurance Investor Live | North America 2026

December 2, 2026

Insurance Investor Live | Europe 2026

Insurance Investor Live | Europe 2026

September 23, 2026

Investing in the Real Economy & Societal Change Forum | Europe 2026

Investing in the Real Economy & Societal Change Forum | Europe 2026

WEBINARS

Short Duration Fixed Income: Unlocking Opportunities for UK Insurers

Short Duration Fixed Income: Unlocking Opportunities for UK Insurers

September 4, 2025

Business Growth and Efficiency: Managing Increasingly Complex Workloads

Business Growth and Efficiency: Managing Increasingly Complex Workloads

November 19, 2024

Addressing Operational Challenges Around Launching a Private Credit Strategy

Addressing Operational Challenges Around Launching a Private Credit Strategy

October 29, 2024

AI in Insurance Strategic Asset Allocation – Ready for the New Disruption?

AI in Insurance Strategic Asset Allocation – Ready for the New Disruption?

October 22, 2024

REPORTS

Winning in Private Markets: How to Boost Efficiency to Enhance Margins and Scale with Demand

Winning in Private Markets: How to Boost Efficiency to Enhance Margins and Scale with Demand

November 10, 2025

Business Growth and Efficiency: Devising your Roadmap to Operational Excellence

Business Growth and Efficiency: Devising your Roadmap to Operational Excellence

September 8, 2025

Business Growth and Efficiency: Navigating Complex Workloads

Business Growth and Efficiency: Navigating Complex Workloads

Insurance Asset Management, North America 2025

Insurance Asset Management, North America 2025

Sponsored

Private equity increases hold on insurers

Private equity increases hold on insurers

(13) January 29, 2026

"Sell America" trend continues - will it be inflationary?

"Sell America" trend continues - will it be inflationary?

(7) January 29, 2026

Fed keeps interest rates steady as inflation fears mount

Fed keeps interest rates steady as inflation fears mount

(6) January 29, 2026

Insurance Investor | European Awards 2026 – ENTRY NOW OPEN

Insurance Investor | European Awards 2026 – ENTRY NOW OPEN

(20) January 28, 2026

How should investors play the “Donroe Doctrine”?

How should investors play the “Donroe Doctrine”?

(57) January 27, 2026

W.R. Berkley nets record investment income in Q4

W.R. Berkley nets record investment income in Q4

(28) January 27, 2026

How to balance growth, risk, and capital management?

How to balance growth, risk, and capital management?

(53) January 26, 2026

Travelers Q4 2025 net investment up 10% year-on-year

Travelers Q4 2025 net investment up 10% year-on-year

(49) January 26, 2026

Are private markets driving massive investment operations uptake in AI?

Are private markets driving massive investment operations uptake in AI?

(40) January 22, 2026

AI tops Risk Barometer for first time with fears of rapid societal change

AI tops Risk Barometer for first time with fears of rapid societal change

(73) January 15, 2026

Fed keeps interest rates steady as inflation fears mount

Fed keeps interest rates steady as inflation fears mount

(0) January 29, 2026

Private equity increases hold on insurers

Private equity increases hold on insurers

(0) January 29, 2026

"Sell America" trend continues - will it be inflationary?

"Sell America" trend continues - will it be inflationary?

(0) January 29, 2026

Insurance Investor | European Awards 2026 – ENTRY NOW OPEN

Insurance Investor | European Awards 2026 – ENTRY NOW OPEN

(0) January 28, 2026

W.R. Berkley nets record investment income in Q4

W.R. Berkley nets record investment income in Q4

(0) January 27, 2026

How should investors play the “Donroe Doctrine”?

How should investors play the “Donroe Doctrine”?

(0) January 27, 2026

How to balance growth, risk, and capital management?

How to balance growth, risk, and capital management?

(0) January 26, 2026

Travelers Q4 2025 net investment up 10% year-on-year

Travelers Q4 2025 net investment up 10% year-on-year

(0) January 26, 2026

Are private markets driving massive investment operations uptake in AI?

Are private markets driving massive investment operations uptake in AI?

(0) January 22, 2026

Is AI a disruptor or the new normal?

Is AI a disruptor or the new normal?

(0) January 15, 2026

FEATURED EVENTS

Europe 2026 and Awards unite insurance investment, treasury, and risk leaders for insight, strategy, and cross-sector excellence recognition. Read More

Join North America 2026 to network with insurance leaders and explore strategies, innovations, and awards recognising investment excellence. Read More

Advertisements

Message Us

Name

Surname

Industry

Email

Message

Terms and Conditions

I agree to the Terms and Conditions

Representative

I confirm that I am a representative of an organisation or acting in the capacity of an Institutional or Professional investor

Terms & Conditions

This page (together with the documents referred to on it) tells you the terms of use on which you may make use of our website www.clearpathanalysis.com (our “site”) and content viewed, requested or received through it, whether as a guest or a registered user. Please read these terms of use carefully before you start to use the site. By using our site, you indicate that you accept these terms of use and that you agree to abide by them. If you do not agree to these terms of use, please refrain from using our site.

1 Information about Us

www.clearpathanalysis.com is a site operated by Clear Path Analysis Limited (“We”). We are registered in England and Wales under company number 07115727 and have our registered office at The Phoenix Yard, 5-9 Upper Brown Street, Leicester, United Kingdom, LE1 5TE. Our main trading address is The Phoenix Yard, 5-9 Upper Brown Street, Leicester, United Kingdom, LE1 5TE. Our VAT number is 983875650. We are a limited company.

2 Accessing our site

2.1 Access to our site is permitted on a temporary basis, and we reserve the right to withdraw or amend the service we provide on our site without notice (see below). We will not be liable if for any reason our site is unavailable at any time or for any period.

2.2 From time to time, we may restrict access to some parts of our site, or our entire site, to users who have registered with us.

2.3 If you choose, or you are provided with, a user identification code, password or any other piece of information as part of our security procedures, you must treat such information as confidential, and you must not disclose it to any third party. We have the right to disable any user identification code or password, whether chosen by you or allocated by us, at any time, if in our opinion you have failed to comply with any of the provisions of these terms of use.

2.4 You are responsible for making all arrangements necessary for you to have access to our site. You are also responsible for ensuring that all persons who access our site through your internet connection are aware of these terms, and that they comply with them.

3 Intellectual property rights

3.1 We are the owner or the licensee of all intellectual property rights in our site, and in the material published on it. Those works are protected by copyright laws and treaties around the world. All such rights are reserved.

3.2 You may print off one copy, and may download extracts, of any page(s) from our site for your personal reference and you may draw the attention of others within your organisation to material posted on our site.

3.3 You must not modify the paper or digital copies of any materials you have printed off or downloaded in any way, and you must not use any illustrations, photographs, video or audio sequences or any graphics separately from any accompanying text.

3.4 Our status (and that of any identified contributors) as the authors of material on our site must always be acknowledged.

3.5 You must not use any part of the materials on our site for commercial purposes without obtaining a licence to do so from us or our licensors.

3.6 If you print off, copy or download any part of our site in breach of these terms of use, your right to use our site will cease immediately and you must, at our option, return or destroy any copies of the materials you have made.

4 Reliance on information posted

4.1 Commentary and other materials posted on our site are not intended to amount to advice on which reliance should be placed. We therefore disclaim all liability and responsibility arising from any reliance placed on such materials by any visitor to our site, or by anyone who may be informed of any of its contents.

4.2 Any data made available on or through our site is made available on an “as is” basis and it is not designed for any particular purpose and we disclaim all liability and responsibility arising from any use made by the data or information on or through our site (whether any such purpose has been communicated to us or otherwise).

5 Our site changes regularly

We aim to update our site regularly, and may change the content at any time. If the need arises, we may suspend access to our site, or close it indefinitely. Any of the material on our site may be out of date at any given time, and we are under no obligation to update such material.

6 Our liability

6.1 The material displayed on our site is provided without any guarantees, conditions or warranties as to its accuracy. To the extent permitted by law, we, other members of our group of companies and third parties connected to us hereby expressly exclude:

6.1.1 All conditions, warranties and other terms which might otherwise be implied by statute, common law or the law of equity.

6.1.2 Any liability for any direct, indirect or consequential loss or damage incurred by any user in connection with our site or in connection with the use, inability to use, or results of the use of our site, any websites linked to it and any materials posted on it, including, without limitation any liability for:

(a) loss of income or revenue;

(b) loss of business;

(c) loss of profits or contracts;

(d) loss of anticipated savings;

(e) loss of data;

(f) loss of goodwill;

(g) wasted management or office time; and

(h) for any other loss or damage of any kind, however arising and whether caused by tort (including negligence), breach of contract or otherwise, even if foreseeable, provided that this condition shall not prevent claims for loss of or damage to your tangible property or any other claims for direct financial loss that are not excluded by any of the categories set out above.

6.1.3 This does not affect our liability for death or personal injury arising from our negligence, nor our liability for fraudulent misrepresentation or misrepresentation as to a fundamental matter, nor any other liability which cannot be excluded or limited under applicable law.

7 Information about you and your visits to our site

We process information about you in accordance with our Privacy Policy [See Privacy Policy below]. By using our site, you consent to such processing and you warrant that all data provided by you is accurate.

8 Transactions concluded through our site

Contracts for the supply of services or information formed through our site or as a result of visits made by you are governed by our terms and conditions of supply.

9 Viruses, hacking and other offences

9.1 You must not misuse our site by knowingly introducing viruses, trojans, worms, logic bombs or other material which is malicious or technologically harmful. You must not attempt to gain unauthorised access to our site, the server on which our site is stored or any server, computer or database connected to our site. You must not attack our site via a denial-of-service attack or a distributed denial-of service attack.

9.2 By breaching this provision, you would commit a criminal offence under the Computer Misuse Act 1990. We will report any such breach to the relevant law enforcement authorities and we will co-operate with those authorities by disclosing your identity to them. In the event of such a breach, your right to use our site will cease immediately.

9.3 We will not be liable for any loss or damage caused by a distributed denial-of-service attack, viruses or other technologically harmful material that may infect your computer equipment, computer programs, data or other proprietary material due to your use of our site or to your downloading of any material posted on it, or on any website linked to it.

10 Linking to our site

10.1 You may link to our home page, provided you do so in a way that is fair and legal and does not damage our reputation or take advantage of it, but you must not establish a link in such a way as to suggest any form of association, approval or endorsement on our part where none exists.

10.2 You must not establish a link from any website that is not owned by you.

10.3 Our site must not be framed on any other site, nor may you create a link to any part of our site other than the home page. We reserve the right to withdraw linking permission without notice.

10.4 If you wish to make any use of material on our site other than that set out above, please address your request to marketing@clearpathanalysis.com.

11 Links from our site

Where our site contains links to other sites and resources provided by third parties, these links are provided for your information only. We have no control over the contents of those sites or resources, and accept no responsibility for them or for any loss or damage that may arise from your use of them.

12 Jurisdiction and applicable law

12.1 The English courts will have nonexclusive jurisdiction over any claim arising from, or related to, a visit to our site although we retain the right to bring proceedings against you for breach of these conditions in your country of residence or any other relevant country.

12.2 These terms of use and any dispute or claim arising out of or in connection with them or their subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with the law of England and Wales.

13 Trademarks

Clear Path and Clear Path Analysis are trademarks Clear Path Analysis Limited.

14 Variations

We may revise these terms of use at any time by amending this page. You are expected to check this page from time to time to take notice of any changes we made, as they are binding on you. Some of the provisions contained in these terms of use may also be superseded by provisions or notices published elsewhere on our site.

15 Your concerns

If you have any concerns about material which appears on our site, please contact marketing@clearpathanalysis.com.